You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

The Real Burden of Rosacea: Patients and Physicians Weigh In

  • Authors: Linda F. Stein Gold, MD; Victor Czerkasij, MSN, NP-C; Emmy M. Graber, MD, MBA
  • CME / ABIM MOC / CE Released: 7/26/2019
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 7/26/2020
Start Activity


Target Audience and Goal Statement

This activity is intended for dermatologists, primary care physicians, pediatricians, and nurses.

The goal of this activity is to highlight the burden of rosacea on patients so that clinicians understand the toll of this condition on patients.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Psychological and physical impact of rosacea on patients' quality of life
  • Have greater competence related to
    • Assessing patients to identify severity and burden of rosacea
    • Using a team approach to incorporate shared decision-making into individualized management plans for patients with different clinical presentations of rosacea


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Moderator

  • Linda Stein Gold, MD

    Director of Clinical Research
    Henry Ford Health System
    Detroit, Michigan

    Disclosures

    Disclosure: Linda F. Stein Gold, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Dermavant Sciences, Inc.; Dermira Inc.; Foamix Pharmaceuticals Ltd.; Galderma Laboratories, L.P.; LEO Pharma Inc.; Ortho Dermatologics; Pfizer Inc.; Sol-Gel Technologies Ltd.
    Served as a speaker or a member of a speakers bureau for: Dermavant Sciences, Inc.; Dermira Inc.; Foamix Pharmaceuticals Ltd.; Galderma Laboratories, L.P.; LEO Pharma Inc.; Ortho Dermatologics; Pfizer Inc.; Sol-Gel Technologies Ltd.
    Received grants for clinical research from: Dermavant Sciences, Inc.; Dermira Inc.; Foamix Pharmaceuticals Ltd.; Galderma Laboratories, L.P.; LEO Pharma Inc.; Ortho Dermatologics; Pfizer Inc.; Sol-Gel Technologies Ltd.

Faculty

  • Victor Czerkasij, MSN, NP-C

    Nurse Practitioner
    The Skin Cancer and Cosmetic Dermatology
    Chattanooga, Tennessee

    Disclosures

    Disclosure: Victor Czerkasij, MSN, NP-C, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Janssen Pharmaceuticals; Novartis Pharmaceuticals Corporation
    Served as a speaker or a member of a speakers bureau for: AbbVie Inc.; Sanofi Aventis; Sun Pharmaceutical Industries, Ltd.

  • Emmy M. Graber, MD, MBA

    President
    The Dermatology Institute of Boston, Massachusetts

    Disclosures

    Disclosure: Emmy M. Graber, MD, MBA, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: 3Derm; Dirigo Therapeutics, LLC; Hovione; Keratin Biosciences Inc.
    Served as a speaker or a member of a speakers bureau for: Allergan, Inc.

Steering Committee

  • Emil Tanghetti, MD

    Owner
    Director
    Center for Dermatology and Laser Surgery
    Sacramento, California, United States

    Disclosures

    Disclosure: Emil Tanghetti, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Accure; Galderma Laboratories, L.P.; Hologic; Lily; Novartis Pharmaceuticals Corporation; Ortho Dermatologics
    Served as a speaker or a member of a speakers bureau for: Accure; Galderma Laboratories, L.P.; Hologic; Novartis Pharmaceuticals Corporation
    Received grants for clinical research from: Hologic
    Owns stock, stock options, or bonds from: Accure

  • Linda F. Stein Gold, MD

    As listed above

  • Emmy M. Graber, MD, MBA

    As listed above

  • Julie C. Harper, MD

    The Dermatology and Skin Care Center of Birmingham
    Birmingham, Alabama, United States

    Disclosures

    Disclosure: Julie C. Harper, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Aclaris; Allergan, Inc.; Aqua Pharmaceuticals; Bayer HealthCare; Biersdorf; Galderma Laboratories, L.P.; Ortho Dermatologics; Sun Pharmaceutical Industries, Ltd.
    Served as a speaker or a member of a speakers bureau for: Aclaris; Allergan, Inc.; Bayer HealthCare; Galderma Laboratories, L.P.; Ortho Dermatologics
    Received grants for clinical research from: Bayer HealthCare

  • J. Mark Jackson, MD

    Clinical Professor of Medicine and Dermatology
    Division of Dermatology
    University of Louisville
    Louisville, Kentucky, United States

    Disclosures

    Disclosure: J. Mark Jackson, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: AbbVie Inc.; Accuitis; Aclaris; Foamix; Galderma Laboratories, L.P.; Innocutis; Janssen Pharmaceuticals; Lilly; Menlo; Novartis Pharmaceuticals Corporation; Promius Pharma, LLC; Ralexar
    Served as a speaker or a member of a speakers bureau for: AbbVie Inc.; Janssen Pharmaceuticals; Lilly; Novartis Pharmaceuticals Corporation
    Received grants for clinical research from: Celgene Corporation; Dr Reddy's; Galderma Laboratories, L.P.; Lilly; Menlo TX; Sienna
    Owns stock, stock options, or bonds from: Accuitis; Ralexar; Top MD

  • Jerry Tan, MD, FRCPC

    Adjunct Professor
    Western University
    London, Ontario, Canada

    Disclosures

    Disclosure: Jerry Tan, MD, FRCPC, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Almirall Hermal GmbH ; Boots; Dermira Inc.; Galderma Laboratories, L.P.; Novan; Novartis Pharmaceuticals Corporation; Valeant Pharmaceuticals International
    Served as a speaker or a member of a speakers bureau for: Cipher; Galderma Laboratories, L.P.
    Received grants for clinical research from: Dermira Inc.; Galderma Laboratories, L.P.; Novan

Editor

  • Chris Washburn, PhD

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Chris Washburn, PhD has disclosed no relevant financial relationships.

CME Reviewer / Nurse Planner

  • Amy Bernard, MS, BSN, RN-BC, CHCP

    Lead Nurse Planner, Medscape, LLC

    Disclosures

    Disclosure: Amy Bernard, MS, BSN, RN-BC, CHCP, has disclosed no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; 0.50 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

The Real Burden of Rosacea: Patients and Physicians Weigh In

Authors: Linda F. Stein Gold, MD; Victor Czerkasij, MSN, NP-C; Emmy M. Graber, MD, MBAFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME / ABIM MOC / CE Released: 7/26/2019

Valid for credit through: 7/26/2020

processing....

Educational Impact Challenge

The goal of this activity is to highlight the burden of rosacea on patients so that clinicians understand the toll of this condition on patients.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.